{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T15:47:59Z","timestamp":1768319279640,"version":"3.49.0"},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"37","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"crossref","award":["R01 AG056392-01"],"award-info":[{"award-number":["R01 AG056392-01"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["R01CA202752"],"award-info":[{"award-number":["R01CA202752"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["RO1DK114485 plus supplement 02S1"],"award-info":[{"award-number":["RO1DK114485 plus supplement 02S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Pennsylvania\/NIH-NIDDK","award":["UO1DK103225"],"award-info":[{"award-number":["UO1DK103225"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Lupus podocytopathy (LP) is an entity that is increasingly being reported in the literature on systemic lupus erythematosus (SLE). LP is characterized by nephrotic syndrome in SLE patients with diffuse glomerular podocyte foot process effacement and no immune complex deposits along the capillary loops. Histologically, LP typically mimics minimal change disease or primary focal segmental glomerulosclerosis (FSGS) on a background of ISN\/RPS class I or II lupus nephritis. In situations where there are coexistent glomerular diseases, however, LP may be easily masked by background lesions and overlapping clinical symptoms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>We report the case of a 24-year-old woman with type I diabetes, hypertension, psoriasis\/rash, and intermittent arthritis who presented with abrupt onset of severe nephrotic proteinuria and renal insufficiency. Renal biopsy revealed nodular glomerulosclerosis and FSGS. Immune deposits were not identified by immunofluorescence or electron microscopy. Ultrastructurally, there was diffuse glomerular basement membrane thickening and over 90% podocyte foot process effacement. With no prior established diagnosis of SLE, the patient was initially diagnosed with diabetic nephropathy with coexistent FSGS, and the patient was started on angiotensin-converting enzyme inhibitors (ACEI) and diuretics. However, nephrotic proteinuria persisted and renal function deteriorated. The patient concurrently developed hemolytic anemia with pancytopenia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Subsequent to the biopsy, serologic results showed positive autoantibodies against double strand DNA (dsDNA), Smith antigen, ribonucleoprotein (RNP), and Histone. A renal biopsy was repeated, revealing essentially similar findings to those of the previous biopsy. Integrating serology and clinical presentation, SLE was favored. The pathology findings were re-evaluated and considered to be most consistent with LP and coexistent diabetic nephropathy, with superimposed FSGS either as a component of LP or as a lesion secondary to diabetes or hypertension.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The patient was started on high-dose prednisone at 60\u200amg\/day, with subsequent addition of mycophenolate mofetil and ACEI, while prednisone was gradually tapered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient's proteinuria, serum creatinine, complete blood counts, skin rash, and arthritis were all significantly improved.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The diagnosis of LP when confounded by other glomerular diseases that may cause nephrotic syndrome can be challenging. Sufficient awareness of this condition is necessary for the appropriate diagnosis and treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000027077","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T13:23:08Z","timestamp":1631884988000},"page":"e27077","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Lupus podocytopathy superimposed on diabetic glomerulosclerosis"],"prefix":"10.1097","volume":"100","author":[{"given":"Lin","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Jacobs School of Medicine, University at Buffalo, State University of New York, Buffalo, NY."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8377-8421","authenticated-orcid":false,"given":"John E.","family":"Tomaszewski","sequence":"additional","affiliation":[{"name":"Department of Pathology and Anatomical Sciences, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, NY"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1053\/j.ackd.2019.08.011","article-title":"Lupus podocytopathy: an overview","volume":"26","author":"Oliva-Damaso","year":"2019","journal-title":"Adv Chronic Kidney Dis"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s40620-017-0463-1","article-title":"Lupus podocytopathy: a distinct entity of lupus nephritis","volume":"31","author":"Chen","year":"2018","journal-title":"J Nephrol"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/ndt\/gfh832","article-title":"Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis","volume":"20","author":"Stokes","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1681\/ASN.2004050350","article-title":"Glomerular podocytopathy in patients with systemic lupus erythematosus","volume":"16","author":"Kraft","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/archinte.1984.00350220141030","article-title":"Steroid-dependent nephrotic syndrome in lupus nephritis. Response to chlorambucil","volume":"144","author":"Abuelo","year":"1984","journal-title":"Arch Intern Med"},{"key":"R6-20250504","first-page":"991","article-title":"Three cases presenting with systemic lupus erythematosus and minimal change nephrotic syndrome","volume":"31","author":"Matsumura","year":"1989","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"R7-20250504","first-page":"835","article-title":"A case report of lupus nephritis associated with minimal change nephrotic syndrome--comparison of various histological types of 67 cases with lupus nephritis","volume":"34","author":"Okai","year":"1992","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0272-6386(12)80382-9","article-title":"Idiopathic focal segmental glomerulosclerosis in a patient with systemic lupus erythematosus: an unusual combination","volume":"23","author":"Hickman","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1159\/000168880","article-title":"Minimal-change nephrotic syndrome associated with systemic lupus erythematosus","volume":"15","author":"Makino","year":"1995","journal-title":"Am J Nephrol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1053\/ajkd.2002.36875","article-title":"SLE and idiopathic nephrotic syndrome: coincidence or not?","volume":"40","author":"Hertig","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5414\/CNP57120","article-title":"Minimal change disease in systemic lupus erythematosus","volume":"57","author":"Dube","year":"2002","journal-title":"Clin Nephrol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2215\/CJN.06720615","article-title":"Clinical-morphological features and outcomes of lupus podocytopathy","volume":"11","author":"Hu","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/0961203318817831","article-title":"Chylous ascites and podocytopathy as the presentation of childhood lupus-an unusual occurrence","volume":"28","author":"Pilania","year":"2019","journal-title":"Lupus"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s10067-015-3069-9","article-title":"Pure lupus podocytopathy first presenting as thrombotic thrombocytopenic purpura-like syndrome","volume":"35","author":"Delgado-Garcia","year":"2016","journal-title":"Clin Rheumatol"},{"key":"R15-20250504","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-227860","article-title":"Haemophagocytic lymphohistiocytosis with collapsing lupus podocytopathy as an unusual manifestation of systemic lupus erythematosus with APOL1 double-risk alleles","volume":"12","author":"Chokshi","year":"2019","journal-title":"BMJ Case Rep"},{"key":"R16-20250504","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-228876","article-title":"Hydroxychloroquine-induced podocytopathy mimicking Fabry disease","volume":"12","author":"Serre","year":"2019","journal-title":"BMJ Case Rep"},{"key":"R17-20250504","first-page":"7869216","article-title":"The various forms of nephrotic syndrome in a patient with systemic lupus erythematosus","volume":"2020","author":"Lionaki","year":"2020","journal-title":"Case Rep Nephrol"},{"key":"R18-20250504","first-page":"6746473","article-title":"Is it coincidence or consequence for a case with antiphospholipid antibody syndrome overlapping SLE to develop an immune complex nephropathy followed by a nonimmune complex podocytopathy?","volume":"2018","author":"Yoo","year":"2018","journal-title":"Case Rep Nephrol"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"2050313X17695997","DOI":"10.1177\/2050313X17695997","article-title":"Recurrent podocytopathy in a patient with systemic lupus erythematosus","volume":"5","author":"Paramalingam","year":"2017","journal-title":"SAGE Open Med Case Rep"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1177\/0961203315578766","article-title":"Glucocorticoid with or without additional immunosuppressant therapy for patients with lupus podocytopathy: a retrospective single-center study","volume":"24","author":"Hu","year":"2015","journal-title":"Lupus"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/rheumatology\/keu265","article-title":"Long-term data on tacrolimus treatment in lupus nephritis","volume":"53","author":"Yap","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1093\/rheumatology\/ket491","article-title":"Podocyte involvement in lupus nephritis based on the 2003\u200aISN\/RPS system: a large cohort study from a single centre","volume":"53","author":"Wang","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"102671","DOI":"10.1016\/j.autrev.2020.102671","article-title":"Rituximab in adult minimal change disease and focal segmental glomerulosclerosis - What is known and what is still unknown?","volume":"19","author":"Gauckler","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/0961203311432740","article-title":"A case of steroid-resistant nephrotic syndrome associated with systemic lupus erythematosus","volume":"23","author":"Ito","year":"2014","journal-title":"Lupus"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10157-012-0606-6","article-title":"Accelerated recovery from nephrotic syndrome with acute renal failure by double filtration plasmapheresis in a patient with lupus podocytopathy","volume":"16","author":"Iwazu","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/01.ASN.0000016406.82019.B3","article-title":"T cells and minimal change disease","volume":"13","author":"Cunard","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1053\/j.ackd.2014.05.010","article-title":"Permeability factors in focal and segmental glomerulosclerosis","volume":"21","author":"Reiser","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"R28-20250504","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0272-6386(12)80381-7","article-title":"Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis","volume":"23","author":"Artero","year":"1994","journal-title":"Am J Kidney Dis"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1399-3046.2011.01478.x","article-title":"Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation","volume":"15","author":"Gonzalez","year":"2011","journal-title":"Pediatr Transplant"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","article-title":"Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis","volume":"17","author":"Wei","year":"2011","journal-title":"Nat Med"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/BOR.0b013e3283562c3e","article-title":"Type I IFN system in the development and manifestations of SLE","volume":"24","author":"Elkon","year":"2012","journal-title":"Curr Opin Rheumatol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2215\/CJN.07311009","article-title":"Treatment with IFN-{alpha}, -{beta}, or -{gamma} is associated with collapsing focal segmental glomerulosclerosis","volume":"5","author":"Markowitz","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1523-1755.2000.00277.x","article-title":"Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo","volume":"58","author":"Brown","year":"2000","journal-title":"Kidney Int"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00125-003-1106-8","article-title":"ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy","volume":"46","author":"Gross","year":"2003","journal-title":"Diabetologia"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.2337\/diabetes.54.6.1626","article-title":"From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy","volume":"54","author":"Wolf","year":"2005","journal-title":"Diabetes"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1172\/JCI119163","article-title":"Podocyte loss and progressive glomerular injury in type II diabetes","volume":"99","author":"Pagtalunan","year":"1997","journal-title":"J Clin Invest"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s001250051447","article-title":"Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria","volume":"42","author":"Meyer","year":"1999","journal-title":"Diabetologia"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1681\/ASN.2004121055","article-title":"TGF-beta concentration specifies differential signaling profiles of growth arrest\/differentiation and apoptosis in podocytes","volume":"16","author":"Wu","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/excr.1993.1043","article-title":"Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis","volume":"204","author":"Pepper","year":"1993","journal-title":"Exp Cell Res"},{"key":"R40-20250504","first-page":"225","article-title":"Epithelia cell foot process width in intact and uninephrectomized diabetic and nondiabetic rats","volume":"43","author":"Steffes","year":"1980","journal-title":"Lab Invest"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1046\/j.1523-1755.2001.00725.x","article-title":"Glomerular cell number in normal subjects and in type 1 diabetic patients","volume":"59","author":"Steffes","year":"2001","journal-title":"Kidney Int"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1046\/j.1523-1755.2000.07717.x","article-title":"Role of vascular endothelial growth factor in diabetic nephropathy","volume":"77","author":"Cha","year":"2000","journal-title":"Kidney Int Suppl"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/jcp.52.10.735","article-title":"Vascular endothelial growth factor mRNA expression in minimal change, membranous, and diabetic nephropathy demonstrated by non-isotopic in situ hybridisation","volume":"52","author":"Bailey","year":"1999","journal-title":"J Clin Pathol"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1038\/sj.ki.5000294","article-title":"Local VEGF activity but not VEGF expression is tightly regulated during diabetic nephropathy in man","volume":"69","author":"Hohenstein","year":"2006","journal-title":"Kidney Int"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/sj.ki.5002101","article-title":"Reduction of VEGF-A and CTGF expression in diabetic nephropathy is associated with podocyte loss","volume":"71","author":"Baelde","year":"2007","journal-title":"Kidney Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:32:38Z","timestamp":1746340358000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000027077"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":45,"journal-issue":{"issue":"37","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000027077","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]},"assertion":[{"value":"2021-04-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}